FT538 in Subjects With Advanced Hematologic Malignancies

Clinical trial NCT04614636 · TERMINATED

Trial details

NCT number

NCT04614636

Sponsor

Fate Therapeutics

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2020-10-17

Primary completion

2023-07-13

Enrollment

42

View on ClinicalTrials.gov